VARIVAX|chicken pox vaccine|chickenpox|varicella|flesh-eating disease VARIVAX ®III is a vaccine containing a live, weakened form of chickenpox virus to help prevent chickenpox (varicella).
Varivax ®(varicella virus vaccine live [Oka/Merck strain]) Chickenpox
Howlong has VARIVAX ®been available?
VARIVAX ®has been available in Canada since 1998.
It has been studied in over 89,000 children and adults and isgenerally well tolerated. Up to now, over 30 million doses have been distributed worldwide.
Who can be vaccinated with VARIVAX ® III?
VARIVAX ®III is recommended for persons age done year and older who have not had chickenpox
How effective is VARIVAX ® III?
According to the National Advisory Committee on Immunization(NACI), "In actual use, it is estimated that the vaccine will offer 70% to 90% protection against varicella of any severity"
How quickly does VARIVAX ® III work?
In clinical trials, antibodies against the varicella virus were observed at 4 to 6 weeks following vaccination with VARIVAX ® III in 97% of children 12 months to 12 years of age.
What is the recommended number of doses for VARIVAX ® III?
Children 12 months to 12 years of age should receive asingle dose of VARIVAX ® III.
Adolescents and adults 13 years of age and older should receive one dose of VARIVAX ®III followed by a second dose 4 to 8 weeks later. The preferred site for the injection is the upper arm.